Federal Register #FDA-2026-N-2741

FDA Request for Information on Market Name Change for Certain Rockfish Species (Sebastes spp.)

The Food and Drug Administration (FDA), under the Department of Health and Human Services, is seeking stakeholder input regarding the potential update of acceptable market names for several rockfish species (Sebastes spp.): - Government Buyer: - Food and Drug Administration (FDA) - Department of Health and Human Services - Purpose: - Request for information (RFI) to inform regulatory decisions on market names for specific Sebastes rockfish species - Species referenced: - Sebastes alutus, S. borealis, S. ciliatus, S. crameri, S. entomelas, S. flavidus, S. goodei, S. levis, S. melanops, S. miniatus, S. ovalis, S. paucispinis, S. pinniger, S. proriger, S. reedi, S. ruberrimus, S. rufus, S. serranoides - Stakeholder input requested on: - Labeling practices - Consumer perceptions - Scientific accuracy - Food safety and allergen labeling - Economic impacts - No products or services are being procured; this is a regulatory information-gathering effort - Notable requirements: - Input should address food safety, regulatory clarity, and industry interests - References to FDA guidance and relevant legislation - Locations: - FDA Dockets Management Staff, Rockville, MD - FDA Human Foods Program, College Park, MD

Description

The Food and Drug Administration (FDA) is requesting data and information to support an evidence-based decision on updating the acceptable market name for several species of Sebastes rockfish. This request aims to balance food safety, regulatory clarity, and industry interests regarding potential changes to the market names of these fish species. The FDA seeks input on consumer perception, scientific accuracy, food safety implications, and economic impacts related to possible new or alternative market names for these rockfish species.

View original listing